These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16061439)

  • 21. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the analytical performance characteristics of the Bayer ACS:180 B-type natriuretic peptide (BNP) assay.
    Wians FH; Wilson BA; Grant A; Bailey J; Gheorghiu I; Conarpe C; Mindicino H; Thakur K; Belenky A; Despres N; Bluestein B
    Clin Chim Acta; 2005 Mar; 353(1-2):147-55. PubMed ID: 15698602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice.
    Mair J; Gerda F; Renate H; Ulmer H; Andrea G; Pachinger O
    Int J Cardiol; 2008 Feb; 124(2):244-6. PubMed ID: 17360054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT-proBNP in chronic hypercapnic respiratory failure: a marker of disease severity, treatment effect and prognosis.
    Budweiser S; Luchner A; Jörres RA; Heinemann F; Hitzl AP; Schmidbauer K; Riegger G; Pfeifer M
    Respir Med; 2007 Sep; 101(9):2003-10. PubMed ID: 17532200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
    Chien TI; Chen HH; Kao JT
    Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
    Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
    Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.
    Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M
    Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.
    Prontera C; Zucchelli GC; Vittorini S; Storti S; Emdin M; Clerico A
    Clin Chim Acta; 2009 Feb; 400(1-2):70-3. PubMed ID: 18992732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.